Wrapmanager Inc. Has $350,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wrapmanager Inc. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 671 shares of the medical equipment provider’s stock after selling 48 shares during the quarter. Wrapmanager Inc.’s holdings in Intuitive Surgical were worth $350,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Bennett Selby Investments LP increased its position in shares of Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after acquiring an additional 17 shares during the last quarter. LVW Advisors LLC lifted its holdings in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. increased its holdings in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares during the period. FSM Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC grew its stake in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 19 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.1 %

Shares of ISRG stock opened at $591.01 on Tuesday. The company has a market capitalization of $210.51 billion, a P/E ratio of 92.20, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The business’s 50 day moving average is $566.43 and its two-hundred day moving average is $526.49. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,240 shares of company stock valued at $3,529,040 in the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on ISRG shares. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Truist Financial raised their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.